Microbiome Therapeutics Market Report

Europe Microbiome Therapeutics Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 06, 2020
  • PAGES：213
  • REPORT CODE：GMM462642
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Microbiome Therapeutics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Microbiome Therapeutics Market Segmentations:

    By Player:

    • Metabogen

    • Symberix

    • Second Genome

    • PureTech

    • Osel

    • Ritter Pharmaceuticals

    • Metabiomics

    • Azitra

    • Seres Therapeutics

    • Rebiotix

    • Synlogic

    • Interxon

    • Assembly Biosciences

    • AOBiome

    • Symbiotix Biotherapies

    • MicroBiome Therapeutics LLC

    • OpenBiome

    • Enterome BioScience

    • 4D Pharma

    • Synthetic Biologics

    • C3 Jian

    By Type:

    • Inflammatory Bowel Disease (IBD)

    • Orphan Drug

    • Immuno-oncology

    • Others

    By End-User:

    • Inflammatory Bowel Disease (IBD)

    • Orphan Drug

    • Immuno-oncology

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Microbiome Therapeutics Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Microbiome Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease (IBD) from 2014 to 2026

    • 1.3.2 Europe Microbiome Therapeutics Market Size and Growth Rate of Orphan Drug from 2014 to 2026

    • 1.3.3 Europe Microbiome Therapeutics Market Size and Growth Rate of Immuno-oncology from 2014 to 2026

    • 1.3.4 Europe Microbiome Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Microbiome Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease (IBD) from 2014 to 2026

    • 1.4.2 Europe Microbiome Therapeutics Market Size and Growth Rate of Orphan Drug from 2014 to 2026

    • 1.4.3 Europe Microbiome Therapeutics Market Size and Growth Rate of Immuno-oncology from 2014 to 2026

    • 1.4.4 Europe Microbiome Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Microbiome Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Microbiome Therapeutics by Major Types

      • 3.4.1 Market Size and Growth Rate of Inflammatory Bowel Disease (IBD)

      • 3.4.2 Market Size and Growth Rate of Orphan Drug

      • 3.4.3 Market Size and Growth Rate of Immuno-oncology

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Microbiome Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Microbiome Therapeutics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Microbiome Therapeutics for Inflammatory Bowel Disease (IBD)

      • 4.4.2 Market Size and Growth Rate of Microbiome Therapeutics for Orphan Drug

      • 4.4.3 Market Size and Growth Rate of Microbiome Therapeutics for Immuno-oncology

      • 4.4.4 Market Size and Growth Rate of Microbiome Therapeutics for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Microbiome Therapeutics Production Analysis by Top Regions

    • 5.2 Europe Microbiome Therapeutics Consumption Analysis by Top Regions

    • 5.3 Europe Microbiome Therapeutics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.3 France Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    6 Product Circulation of Microbiome Therapeutics Market among Top Countries

    • 6.1 Top 5 Export Countries in Microbiome Therapeutics Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Microbiome Therapeutics Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Microbiome Therapeutics Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Microbiome Therapeutics Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Microbiome Therapeutics Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Microbiome Therapeutics Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Microbiome Therapeutics Landscape Analysis

    • 7.1 Germany Microbiome Therapeutics Landscape Analysis by Major Types

    • 7.2 Germany Microbiome Therapeutics Landscape Analysis by Major End-Users

    8. UK Microbiome Therapeutics Landscape Analysis

    • 8.1 UK Microbiome Therapeutics Landscape Analysis by Major Types

    • 8.2 UK Microbiome Therapeutics Landscape Analysis by Major End-Users

    9. France Microbiome Therapeutics Landscape Analysis

    • 9.1 France Microbiome Therapeutics Landscape Analysis by Major Types

    • 9.2 France Microbiome Therapeutics Landscape Analysis by Major End-Users

    10. Italy Microbiome Therapeutics Landscape Analysis

    • 10.1 Italy Microbiome Therapeutics Landscape Analysis by Major Types

    • 10.2 Italy Microbiome Therapeutics Landscape Analysis by Major End-Users

    11. Spain Microbiome Therapeutics Landscape Analysis

    • 11.1 Spain Microbiome Therapeutics Landscape Analysis by Major Types

    • 11.2 Spain Microbiome Therapeutics Landscape Analysis by Major End-Users

    12. Poland Microbiome Therapeutics Landscape Analysis

    • 12.1 Poland Microbiome Therapeutics Landscape Analysis by Major Types

    • 12.2 Poland Microbiome Therapeutics Landscape Analysis by Major End-Users

    13. Russia Microbiome Therapeutics Landscape Analysis

    • 13.1 Russia Microbiome Therapeutics Landscape Analysis by Major Types

    • 13.2 Russia Microbiome Therapeutics Landscape Analysis by Major End-Users

    14. Switzerland Microbiome Therapeutics Landscape Analysis

    • 14.1 Switzerland Microbiome Therapeutics Landscape Analysis by Major Types

    • 14.2 Switzerland Microbiome Therapeutics Landscape Analysis by Major End-Users

    15. Turkey Microbiome Therapeutics Landscape Analysis

    • 15.1 Turkey Microbiome Therapeutics Landscape Analysis by Major Types

    • 15.2 Turkey Microbiome Therapeutics Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Landscape Analysis by Top Countries

      • 16.3.1 Denmark Microbiome Therapeutics Market Volume and Growth Rate

      • 16.3.2 Finland Microbiome Therapeutics Market Volume and Growth Rate

      • 16.3.3 Norway Microbiome Therapeutics Market Volume and Growth Rate

      • 16.3.4 Sweden Microbiome Therapeutics Market Volume and Growth Rate

      • 16.3.6 Iceland Microbiome Therapeutics Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Landscape Analysis by Top Countries

      • 17.3.1 Belgium Microbiome Therapeutics Market Volume and Growth Rate

      • 17.3.2 Netherlands Microbiome Therapeutics Market Volume and Growth Rate

      • 17.3.3 Luxembourg Microbiome Therapeutics Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Landscape Analysis by Top Countries

      • 18.3.1 Estonia Microbiome Therapeutics Market Volume and Growth Rate

      • 18.3.2 Latvia Microbiome Therapeutics Market Volume and Growth Rate

      • 18.3.3 Lithuania Microbiome Therapeutics Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Metabogen

      • 19.1.1 Metabogen Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Symberix

      • 19.2.1 Symberix Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Second Genome

      • 19.3.1 Second Genome Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 PureTech

      • 19.4.1 PureTech Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Osel

      • 19.5.1 Osel Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Ritter Pharmaceuticals

      • 19.6.1 Ritter Pharmaceuticals Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Metabiomics

      • 19.7.1 Metabiomics Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Azitra

      • 19.8.1 Azitra Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Seres Therapeutics

      • 19.9.1 Seres Therapeutics Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Rebiotix

      • 19.10.1 Rebiotix Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Synlogic

      • 19.11.1 Synlogic Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Interxon

      • 19.12.1 Interxon Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Assembly Biosciences

      • 19.13.1 Assembly Biosciences Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 AOBiome

      • 19.14.1 AOBiome Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Symbiotix Biotherapies

      • 19.15.1 Symbiotix Biotherapies Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 MicroBiome Therapeutics LLC

      • 19.16.1 MicroBiome Therapeutics LLC Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 OpenBiome

      • 19.17.1 OpenBiome Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Enterome BioScience

      • 19.18.1 Enterome BioScience Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 4D Pharma

      • 19.19.1 4D Pharma Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Synthetic Biologics

      • 19.20.1 Synthetic Biologics Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 C3 Jian

      • 19.21.1 C3 Jian Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    The List of Tables and Figures (Totals 101 Figures and 123 Tables)

    • Figure Product Picture

    • Figure Europe Microbiome Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease (IBD) from 2014 to 2026

    • Figure Europe Microbiome Therapeutics Market Size and Growth Rate of Orphan Drug from 2014 to 2026

    • Figure Europe Microbiome Therapeutics Market Size and Growth Rate of Immuno-oncology from 2014 to 2026

    • Figure Europe Microbiome Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Microbiome Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease (IBD) from 2014 to 2026

    • Figure Europe Microbiome Therapeutics Market Size and Growth Rate of Orphan Drug from 2014 to 2026

    • Figure Europe Microbiome Therapeutics Market Size and Growth Rate of Immuno-oncology from 2014 to 2026

    • Figure Europe Microbiome Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure UK Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure France Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Microbiome Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Microbiome Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Microbiome Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Microbiome Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of Microbiome Therapeutics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Inflammatory Bowel Disease (IBD)

    • Figure Market Size and Growth Rate of Orphan Drug

    • Figure Market Size and Growth Rate of Immuno-oncology

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Microbiome Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Microbiome Therapeutics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Inflammatory Bowel Disease (IBD)

    • Figure Market Size and Growth Rate of Orphan Drug

    • Figure Market Size and Growth Rate of Immuno-oncology

    • Figure Market Size and Growth Rate of Others

    • Table Europe Microbiome Therapeutics Production by Major Regions

    • Table Europe Microbiome Therapeutics Production Share by Major Regions

    • Figure Europe Microbiome Therapeutics Production Share by Major Countries and Regions in 2014

    • Table Europe Microbiome Therapeutics Consumption by Major Regions

    • Table Europe Microbiome Therapeutics Consumption Share by Major Regions

    • Table Germany Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table UK Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table France Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Italy Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Spain Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Poland Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Russia Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Switzerland Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Turkey Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Microbiome Therapeutics Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Microbiome Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Microbiome Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Microbiome Therapeutics Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Germany Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Germany Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Germany Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table UK Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table UK Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table UK Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table UK Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table France Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table France Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table France Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table France Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Italy Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Italy Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Italy Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Italy Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Spain Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Spain Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Spain Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Spain Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Poland Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Poland Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Poland Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Poland Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Russia Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Russia Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Russia Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Russia Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Switzerland Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Switzerland Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Switzerland Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Turkey Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Turkey Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Turkey Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Microbiome Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Microbiome Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Microbiome Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Metabogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Metabogen

    • Figure Sales and Growth Rate Analysis of Metabogen

    • Figure Revenue and Market Share Analysis of Metabogen

    • Table Product and Service Introduction of Metabogen

    • Table Company Profile and Development Status of Symberix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Symberix

    • Figure Sales and Growth Rate Analysis of Symberix

    • Figure Revenue and Market Share Analysis of Symberix

    • Table Product and Service Introduction of Symberix

    • Table Company Profile and Development Status of Second Genome

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Second Genome

    • Figure Sales and Growth Rate Analysis of Second Genome

    • Figure Revenue and Market Share Analysis of Second Genome

    • Table Product and Service Introduction of Second Genome

    • Table Company Profile and Development Status of PureTech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PureTech

    • Figure Sales and Growth Rate Analysis of PureTech

    • Figure Revenue and Market Share Analysis of PureTech

    • Table Product and Service Introduction of PureTech

    • Table Company Profile and Development Status of Osel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Osel

    • Figure Sales and Growth Rate Analysis of Osel

    • Figure Revenue and Market Share Analysis of Osel

    • Table Product and Service Introduction of Osel

    • Table Company Profile and Development Status of Ritter Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ritter Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ritter Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ritter Pharmaceuticals

    • Table Product and Service Introduction of Ritter Pharmaceuticals

    • Table Company Profile and Development Status of Metabiomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Metabiomics

    • Figure Sales and Growth Rate Analysis of Metabiomics

    • Figure Revenue and Market Share Analysis of Metabiomics

    • Table Product and Service Introduction of Metabiomics

    • Table Company Profile and Development Status of Azitra

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Azitra

    • Figure Sales and Growth Rate Analysis of Azitra

    • Figure Revenue and Market Share Analysis of Azitra

    • Table Product and Service Introduction of Azitra

    • Table Company Profile and Development Status of Seres Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seres Therapeutics

    • Figure Sales and Growth Rate Analysis of Seres Therapeutics

    • Figure Revenue and Market Share Analysis of Seres Therapeutics

    • Table Product and Service Introduction of Seres Therapeutics

    • Table Company Profile and Development Status of Rebiotix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rebiotix

    • Figure Sales and Growth Rate Analysis of Rebiotix

    • Figure Revenue and Market Share Analysis of Rebiotix

    • Table Product and Service Introduction of Rebiotix

    • Table Company Profile and Development Status of Synlogic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synlogic

    • Figure Sales and Growth Rate Analysis of Synlogic

    • Figure Revenue and Market Share Analysis of Synlogic

    • Table Product and Service Introduction of Synlogic

    • Table Company Profile and Development Status of Interxon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Interxon

    • Figure Sales and Growth Rate Analysis of Interxon

    • Figure Revenue and Market Share Analysis of Interxon

    • Table Product and Service Introduction of Interxon

    • Table Company Profile and Development Status of Assembly Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Assembly Biosciences

    • Figure Sales and Growth Rate Analysis of Assembly Biosciences

    • Figure Revenue and Market Share Analysis of Assembly Biosciences

    • Table Product and Service Introduction of Assembly Biosciences

    • Table Company Profile and Development Status of AOBiome

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AOBiome

    • Figure Sales and Growth Rate Analysis of AOBiome

    • Figure Revenue and Market Share Analysis of AOBiome

    • Table Product and Service Introduction of AOBiome

    • Table Company Profile and Development Status of Symbiotix Biotherapies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Symbiotix Biotherapies

    • Figure Sales and Growth Rate Analysis of Symbiotix Biotherapies

    • Figure Revenue and Market Share Analysis of Symbiotix Biotherapies

    • Table Product and Service Introduction of Symbiotix Biotherapies

    • Table Company Profile and Development Status of MicroBiome Therapeutics LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MicroBiome Therapeutics LLC

    • Figure Sales and Growth Rate Analysis of MicroBiome Therapeutics LLC

    • Figure Revenue and Market Share Analysis of MicroBiome Therapeutics LLC

    • Table Product and Service Introduction of MicroBiome Therapeutics LLC

    • Table Company Profile and Development Status of OpenBiome

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OpenBiome

    • Figure Sales and Growth Rate Analysis of OpenBiome

    • Figure Revenue and Market Share Analysis of OpenBiome

    • Table Product and Service Introduction of OpenBiome

    • Table Company Profile and Development Status of Enterome BioScience

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Enterome BioScience

    • Figure Sales and Growth Rate Analysis of Enterome BioScience

    • Figure Revenue and Market Share Analysis of Enterome BioScience

    • Table Product and Service Introduction of Enterome BioScience

    • Table Company Profile and Development Status of 4D Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 4D Pharma

    • Figure Sales and Growth Rate Analysis of 4D Pharma

    • Figure Revenue and Market Share Analysis of 4D Pharma

    • Table Product and Service Introduction of 4D Pharma

    • Table Company Profile and Development Status of Synthetic Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthetic Biologics

    • Figure Sales and Growth Rate Analysis of Synthetic Biologics

    • Figure Revenue and Market Share Analysis of Synthetic Biologics

    • Table Product and Service Introduction of Synthetic Biologics

    • Table Company Profile and Development Status of C3 Jian

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of C3 Jian

    • Figure Sales and Growth Rate Analysis of C3 Jian

    • Figure Revenue and Market Share Analysis of C3 Jian

    • Table Product and Service Introduction of C3 Jian

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US